about
Prevalence of monoclonal gammopathy of undetermined significance: a systematic reviewEuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesAdvances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaIncidence and survival in non-hereditary amyloidosis in SwedenMusculoskeletal disorders among cosmetologistsRace and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.Association of VEGF and VDR gene- gene and gene- smoking interaction on risk of multiple myeloma in Chinese Han population.Robert Arthur Kyle, MD: a conversation with the editor.Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.A case of multiple myeloma in a poultry worker.Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options.Second malignancies after multiple myeloma: from 1960s to 2010s.Effect of autoimmune diseases on incidence and survival in subsequent multiple myelomaManagement of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis.Renal amyloidosis in children.Pomalidomide for multiple myeloma.Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).Multiple myeloma: a descriptive study of 217 Egyptian patients.Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis.Search for familial clustering of multiple myeloma with any cancer.Cell Trafficking in Multiple MyelomaAnalytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases.The significance of monoclonal gammopathy of undetermined significance.Prevalence of monoclonal gammopathy of undetermined significance in Thailand.Current applications of multiparameter flow cytometry in plasma cell disorders.Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma.Healthcare costs of multiple myeloma: an Italian study.Alcohol intake, alcoholic beverage type and multiple myeloma risk: a meta-analysis of 26 observational studiesTobacco smoking and risk of multiple myeloma: A meta-analysis of 40 observational studiesAbnormal Plasma Cell Disorders in Refinery Waste WorkersBiological determinants of health disparities in multiple myeloma
P2860
Q24597406-96A39C80-F159-4ECE-8777-F66A0401DDA2Q24604581-5018DE8A-2431-4C84-BC7A-C82462B6E2E0Q24619589-D3FE0775-2BEB-4949-A283-C9E3E943E208Q31106882-D95A5148-E3B2-4043-96DB-E1454B7DF717Q33566903-7E9A5476-ED78-4067-A3CE-252CF39110E8Q33708469-31BCB1B7-0DA3-4AAA-9075-E449D7B0851FQ33829546-B9EEE8FD-E69F-4308-9B78-302990EB054CQ34145491-F49CC3A5-21B2-41AF-BFB4-EC5E8F41E020Q34307388-58D2ACF6-19A2-482C-AF11-82F52A294BC8Q34788114-32E0B480-C46E-4989-81F1-E44FD2CAB534Q35410550-542D0A80-167C-4FBD-BFA1-4FF3CB02D1DFQ35678932-89DDA398-FA68-47C9-AAD1-EA47ED3E83BDQ35891594-DC9F0E3D-B245-4FEC-AF2D-700953A1D0DCQ36323304-307E67F9-4151-4555-BF6A-6A5E5928E7ACQ37582168-3A521B1D-65FA-4AF8-988D-54364955DEEBQ37708798-A90D1610-BA60-4E88-A61A-7B529818C170Q37848210-D09ED20E-8EDB-45D7-8C8E-EE7080FC598CQ38255265-CD69B7D8-BF32-4F01-BD74-221CF6C3277AQ38554884-640AA4E7-6F4B-4E33-B0C9-901E64904338Q38856161-9C1CB58F-4633-4A7C-9D43-04E535E0A16AQ38984747-2CC97126-5996-49DB-A510-F82F98D44AD9Q39594256-207CD9F7-3D7F-4116-9223-97BA24B93394Q41245666-691B1A14-2F01-4753-B3E0-9B4317E63025Q42146660-500B9617-BBCC-45D0-B714-9D25E36D1293Q42356395-03668649-BC80-4AFE-9965-94A7375F06C9Q42956319-EF07B4B9-BF30-4E51-AD38-E6074C8BAAAFQ44378912-C509F4A3-EB96-482D-AAB5-A8EEE2229D96Q47110039-70FAE4D2-998F-4EBE-966F-E1A861ECF908Q48680853-FB884C45-03C0-4BA0-9F83-DBE3051B866AQ51141458-17EF2989-2DD0-4C2C-A6D5-1E8CF455F2F9Q57904262-E9A74AF0-6397-45A8-B7EB-1E41413F5166Q57904435-D22D7388-B249-4DB7-A34B-076729B30D42Q58089507-21790656-609C-48B1-B9E0-AB8F998EF903Q58697873-10C413B1-D638-4664-87A3-40963B7E5081
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Epidemiology of the plasma-cell disorders
@ast
Epidemiology of the plasma-cell disorders
@en
Epidemiology of the plasma-cell disorders
@nl
type
label
Epidemiology of the plasma-cell disorders
@ast
Epidemiology of the plasma-cell disorders
@en
Epidemiology of the plasma-cell disorders
@nl
prefLabel
Epidemiology of the plasma-cell disorders
@ast
Epidemiology of the plasma-cell disorders
@en
Epidemiology of the plasma-cell disorders
@nl
P1476
Epidemiology of the plasma-cell disorders
@en
P304
P356
10.1016/J.BEHA.2007.08.001
P407
P577
2007-12-01T00:00:00Z